<unk>  is an hemostatic that is FDA approved for the treatment of hemorrhage.   Common adverse reactions include prolonged activated partial thromboplastin time, increased INR, lymphocytopenia, prolonged prothrombin time and neutrophilia.
Thrombin human
Thrombus precursor protein 
Coagulation factor VIIa
Factor ix complex
Coagulation factor IX
Factor IX complex
Fibrin
Coagulation factor XIII A-subunit